Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1591-1600 of 2905 for cancer

Edit search filters
  1. Erlotinib Hydrochloride In Preventing Liver Cancer In Patients With Cirrhosis Of The Liver Undergoing Surgery

    Jacksonville, FL, Rochester, MN

  2. Phase II Study Of Tipifarnib In Squamous Head And Neck Cancer With HRAS Mutations

    Rochester, MN

  3. Tucatinib, Trastuzumab, Ramucirumab, And Paclitaxel Versus Paclitaxel And Ramucirumab In Previously Treated HER2+ Gastroesophageal Cancer

    Scottsdale/Phoenix, AZ

  4. Wearable EEG Headband As A Meditation Device For Breast Cancer Survivors

    Rochester, MN

  5. Observation In Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection

    Rochester, MN

  6. Metformin As A Chemoprevention Agent In Non-small Cell Lung Cancer

    Rochester, MN

  7. PET Scan Imaging In Assessing Response In Patients With Esophageal Cancer Receiving Combination Chemotherapy

    Rochester, MN

  8. Dignity Therapy/Life Plan In Patients With Pancreatic Or Advanced Lung Cancer

    Rochester, MN

  9. A Study To Evaluate Exemestane In Post-Menopausal Women With Non-Small Cell Lung Cancer (NSCLC)

    Albert Lea, MN, Mankato, MN

  10. A Study Of Rucaparib In Patients With Pancreatic Cancer And A Known Deleterious BRCA Mutation

    Rochester, MN

.

Mayo Clinic Footer